In this study, the effect of molybdenum content in Ti-15Zr-based alloys (wt%) was analyzed in terms of crystalline structure, microstructure, selected mechanical properties, and cytotoxicity.The samples were produced by argon arc-melting followed by hot rolling and heat treatment processes.The crystalline structure and microstructure were dependent of both alloying elements (zirconium and molybdenum).Ti-15Zr alloy displayed only laths of a 0 phase, while the alloys up to Ti-15Zr-10Mo exhibited different proportions of a 0 , a", and b phases.Molybdenum content higher than 12.5 wt% fully stabilized the b phase.Vickers microhardness values of Ti-15Zr-Mo alloys were higher than those of CP-Ti due to solid solution and phase precipitation strengthening.Young's modulus values of Ti-15Zr-Mo alloys were lower than those of CP-Ti due to b phase stabilization.Cytotoxicity levels of Ti-15Zr-Mo alloys were within a tolerable range for biomedical purposes.In addition, we observed molybdenum content in Ti-15Zr-based alloys promoted an increase on pre-osteoblast adhesion up to 3 h of adhesion's time.Thus, Ti-15Zr-15Mo alloy presented better combination of properties than some traditional metallic biomaterials.
No takes yet. Share an insight, caveat, or question.
Corrêa et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: